- Tytuł:
- A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer
- Autorzy:
- Źródło:
- In Gynecologic Oncology December 2020 159(3):692-698
Czasopismo naukowe